Drug Shortage Report for DALMACOL

Last updated on 2019-04-17 History
Report ID 58270
Drug Identification Number 02230769
Brand name DALMACOL
Common or Proper name Dalmacol
Company Name LABORATOIRE RIVA INC.
Market Status MARKETED
Active Ingredient(s) DOXYLAMINE SUCCINATE SODIUM CITRATE HYDROCODONE BITARTRATE ALCOHOL ANHYDROUS ETAFEDRIN HYDROCHLORIDE
Strength(s) 1.2MG 40MG .33MG .05ML 3.33MG
Dosage form(s) SYRUP
Route of administration ORAL
Packaging size 2L
ATC code R05DA
ATC description COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-08-22
Actual start date 2018-08-22
Estimated end date 2018-12-01
Actual end date 2018-12-01
Shortage status Resolved
Updated date 2019-04-17
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 660 BOUL. INDUSTRIEL
BLAINVILLE, QUEBEC
CANADA J7C 3V4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2019-04-17 French Compare
v8 2019-04-17 English Compare
v7 2019-04-11 French Compare
v6 2019-04-11 English Compare
v5 2018-10-01 French Compare
v4 2018-10-01 English Compare
v3 2018-08-23 English Compare
v2 2018-08-16 French Compare
v1 2018-08-16 English Compare

Showing 1 to 9 of 9